Those who completed the two-dose regimen for Pfizer’s COVID-19 vaccine will likely need a third shot within 12 months, CEO Albert Bourla said. There is also a chance people will…
Read More Third Pfizer COVID-19 vaccine dose ‘likely’ needed within year, CEO says
The US Food and Drug Administration (FDA) together with the Centers for Disease Control and Prevention (CDC) is recommending a pause in the rollout of the Johnson & Johnson COVID-19…
Read More US halts use of Johnson & Johnson COVID-19 vaccine after blood clot cases
Ebun Francis| The National Agency for Food, Drug Administration and Control (NAFDAC) has confirmed that substances behind strange illness in Kano state were laced with “hydroxylamine” — a chemical used…
Read More Substances behind strange illness in Kano laced with poison – NAFDAC
The coronavirus variant discovered in South Africa may evade the protection provided by Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in…
Read More South African variant may evade protection from Pfizer vaccine, Israeli study says
As uncertainty over the overall safety of the Oxford-AstraZeneca vaccine jab continues, three European countries, UK, Italy, and Belgium announced the restriction of its use following link between the vaccine…
Read More Uncertainty over Oxford-AstraZeneca vaccine lingers as UK, Italy, Belgium restrict use
